amitriptyline has been researched along with CJD (Creutzfeldt-Jakob Disease) in 2 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Paolini Paoletti, F | 1 |
| Di Gregorio, M | 1 |
| Calabresi, P | 1 |
| Parnetti, L | 1 |
| Foerstl, J | 1 |
| Hohagen, F | 1 |
| Hewer, W | 1 |
| Pohlmann-Eden, B | 1 |
2 other studies available for amitriptyline and CJD (Creutzfeldt-Jakob Disease)
| Article | Year |
|---|---|
Drug-induced Creutzfeldt-Jakob disease-like syndrome: early CSF analysis as useful tool for differential diagnosis.
Topics: Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Clomipramine; Cognitive Dysfunction; Creutzfe | 2018 |
Another case of Creutzfeldt-Jakob like syndrome due to antidepressant toxicity.
Topics: Amitriptyline; Creutzfeldt-Jakob Syndrome; Depressive Disorder; Dose-Response Relationship, Drug; Fe | 1989 |